| 19675859 |
Pagou M, Zerizer I, Al-Nahhas A: Can gallium-68 compounds partly replace (18) F-FDG in PET molecular imaging?. Hell J Nucl Med. 2009 May-Aug;12(2):102-5.
In vitro and animal testing are still progressing alongside clinical studies, with promising results in the use of (68) Ga-DOTA-rhenium-cyclized alpha-melanocyte stimulating hormone (MSH) and (68) Ga-DOTA-napamide (NAP) in melanoma, (68) Ga-DOTA-PEG (4)-BN (7-14) (PESIN) for the imaging of bombesin receptor- positive tumours and (68) Ga-ethylene dicysteine-metronidazole (EC-MN) for imaging tumour hypoxia. |
81(1,1,1,1) |
Details |